← Back to all trials
Recruiting
NCT07673237
Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
Conditions: Fibrotic Interstitial Lung Disease, IPF and PPF, Lung Fibrosis Interstitial
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 200
Sponsor: University of California, San Francisco
Location: University of California, San Francisco San Francisco California
Summary
The purpose of this interventional study is to identify which combination of remote monitoring devices (e.g. home spirometry, pulse oximetry, scale, ePROs) is the most feasible (as defined by adherence, retention, and data completeness) and acceptable when used for the detection of clinically significant Interstitial Lung Disease events.
Eligibility Criteria
Inclusion Criteria:
* age 18 or older
* English speaking
* have a UCSF diagnosis of one of the major ILD subtypes seen in the ILD Clinic (Idiopathic Pulmonary Fibrosis, Chronic Hypersensitivity Pneumonitis, Connective-tissue disease related ILD, Sarcoidosis, Familial Fibrosis). Languages are limited to those for which both device instructional materials and user support are available (written and video). The ILD diagnosis will be based on multidisciplinary conference review, which is the diagnostic gold standard. We have restricted the ILD subtypes to those for which there is efficacy data for RPM or comparable clinical trajectories, and subtypes that account for \>10% of the ILD diagnoses seen at UCSF.
Exclusion Criteria:
* Patients who are unable provide informed consent for any reason or are acutely ill.
Source: ClinicalTrials.gov (NCT07673237). StuddyBuddy aggregates publicly available trial information.